Patient P-02213
Synthetic patientMETA-24 · Day 167 · 45–54 · M · baseline S13Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
21%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S13
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+8
- Inflammatory activity+5
- Toxicity+4
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable41 min
improving · +7.2 vs previous 14 d
Sleep duration
Wearable7.5 h
improving · +0.3 vs previous 14 d
Energy level
Daily log7/10
stable · -0.0 vs previous 14 d
Steps
Wearable4,806
improving · +460 vs previous 14 d
GI burden
Companion15.3/100
improving · -2.6 vs previous 14 d
Adherence
Companion88.8 %
worsening · -4.7 vs previous 14 d
Sleep quality
Wearable59.2/100
improving · +7.2 vs previous 14 d
Glucose, CGM daily mean
CGM129 mg/dL
stable · -3.8 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 93 from the failing basin, 8 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -7.1 next day on high-intake days · n 17
Would not help
- Keep histamine lowGI +6 next day on high-intake days · n 25
- Keep alcohol lowGI +5.7 next day on high-intake days · n 16
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-7.1supporter · 95%
- Histamine load+6detractor · 95%
- Alcohol+5.7detractor · 95%
- Dietary fat load+1.7no signal · 32%
- Ultra-processed food+1.6no signal · 29%
- Insoluble fibre+0.9no signal · 17%
- Caffeine-0.8no signal · 15%
- Simple carbohydrates-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4 · butyrate capacity 47/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 58 ms
- Sleep
- 7.5 h
- Steps
- 4,282
- Resting HR
- 64 bpm
Daily log: GI score 15, nutritional resilience 69, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.